about
Simultaneous chiral analyses of multiple analytes: case studies, implications and method development considerations.Chromatographic and electrophoretic strategies for the chiral separation and quantification of d- and l-threo methylphenidate in biological matrices.Chirality as a tool in nucleic acid recognition: principles and relevance in biotechnology and in medicinal chemistry.A mechanistic approach for the DNA binding of chiral enantiomeric L- and D-tryptophan-derived metal complexes of 1,2-DACH: cleavage and antitumor activity.Biological activity of enantiomeric complexes [PtCl(2)L (2)] (L (2) is aromatic bisphosphanes and aromatic diamines).Water-soluble organometallic analogues of oxaliplatin with cytotoxic and anticlonogenic activity.Enantiomerically pure [1, 2-diamino-1-(4-fluorophenyl)butane]platinum(II) complexes: synthesis and antitumor activity against MCF-7 and MDA-MB 231 breast cancer and LnCaP/FGC prostate cancer cell lines.Structural dynamics of cisplatin binding to histidine in a protein.Experimental evidence that a DNA polymerase can incorporate N7-platinated guanines to give platinated DNA.An unsymmetric cisplatin-based Pt(iv) derivative containing 2-(2-propynyl)octanoate: a very efficient multi-action antitumor prodrug candidate.Enantioselective targeting left-handed Z-G-quadruplex.Polypyridyl Zinc(II)-Indomethacin Complexes with Potent Anti-Breast Cancer Stem Cell Activity
P2860
Q33209645-D02C9FD6-37E8-4C41-A0E3-92AE6C015C50Q35241765-5B2FF826-3440-45CD-9467-725E05148F4EQ36754262-CE3771BB-117F-437C-A2D5-0D15BFCDE26BQ39647326-10B4A9C6-2169-4CE8-9F0C-8C2FD2F870B9Q39723723-8B3774B2-9302-4CD1-B2A4-11987C097370Q39768981-F799C86F-E95D-406F-8755-07C2DBBB07CBQ40481000-47188B40-3FC4-4D63-BEB2-2C272214E0E4Q43090240-8CF89D08-FA23-4678-BBE9-B3F88487A322Q46866457-90EEE9A3-B6B0-44CC-934C-602A585A01FAQ49563999-E9F172AB-E927-4628-8CCD-3B1C42DBF169Q53401327-C43F2F1B-5364-49C9-A4A0-42ED5D409BFEQ58691268-97244E6A-F3CC-417F-BD18-D9D2AB705F01
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Chiral discrimination in platinum anticancer drugs
@nl
Chiral discrimination in platinum anticancer drugs.
@ast
Chiral discrimination in platinum anticancer drugs.
@en
type
label
Chiral discrimination in platinum anticancer drugs
@nl
Chiral discrimination in platinum anticancer drugs.
@ast
Chiral discrimination in platinum anticancer drugs.
@en
prefLabel
Chiral discrimination in platinum anticancer drugs
@nl
Chiral discrimination in platinum anticancer drugs.
@ast
Chiral discrimination in platinum anticancer drugs.
@en
P2093
P2860
P356
P1476
Chiral discrimination in platinum anticancer drugs
@en
P2093
Giovanni Natile
Jana Kasparkova
Michele Benedetti
P2860
P304
P356
10.1289/EHP.02110S5779
P407
P478
110 Suppl 5
P577
2002-10-01T00:00:00Z